Israel was one of the first heavily vaccinated countries; now it leads in vaccinated infection.
A Pfizer executive has described Israel as a unique “laboratory” to assess COVID jab effects, saying whatever happens there can reliably be expected to happen elsewhere, months later.
Israel’s N12 News obtained a recording of a Zoom meeting with academics in which a Pfizer vice president and its chief scientist, Dr. Philip Dormitizer, discussed the waning effectiveness of the vaccine, referring to Israel as a laboratory because of high vaccination rates and a deal with the Israeli Ministry of Health to use Pfizer’s vaccine exclusively.
“What we see happening in Israel, happens again in the United States a couple months later,” he said in a video recording of the Zoom meeting.
In other words, the Israeli population is one giant test group—without a control group, unfortunately—and as noted by the news anchors, the people really should have been informed that they were part of one of the biggest medical experiments in human history.
Pfizer entered into an exclusivity agreement with the Israeli Ministry of Health at the outset, so the only COVID-19 shot available is Pfizer’s. As noted by the news anchor, we now realize that the Pfizer shot has a higher risk for heart inflammation among young men than some of the other COVID-19 shots, but Israeli youth have no option but to get the most dangerous shot.
Israel Rolls Out Booster Shots
Israel was one of the first countries to implement draconian vaccination mandates, even though the Pfizer shot was completely experimental. Israelis were told they couldn’t enter certain venues without a vaccination card, such as restaurants, gyms, swimming pools, and hotels.
As a result, it now has one of the highest vaccination rates in the world. As of mid-September, nearly 14.6 million doses had been administered. At two doses, that would give it a vaccination rate of 80.5 percent. It’s probably a bit less than that, because Israel started giving out third boosters at the end of July.
The first group to qualify for a third shot were seniors over the age of 60. Less than three weeks later, eligibility expanded to include people over the age of 40, as well as pregnant women, teachers, and health care workers, even if they’re younger than 40. By the end of August, boosters were offered to all previously vaccinated individuals, all the way down to the age of 12.
By the second week of September, when an estimated 2.8 million Israelis had received a third dose, a possible fourth dose was already being prepared.
Health Ministry Director-General Nachman Ash told Radio 103FM that officials still don’t know when a fourth dose might be needed, but clearly, there’s no indication that the boosters won’t continue. And each time that happens, the people will forfeit their freedoms all over again, until they get the next shot.
Israeli Data Considered the Best Around
If there’s a silver lining to this experiment, it’s that Israel at least appears to be far more diligent and transparent in its data collection than the United States. The data coming out of Israel is considered by many to be the best in the world because of its commitment to transparency. As explained by Science magazine:
“The nation of 9.3 million … has a robust public health infrastructure and a population wholly enrolled in HMOs that track them closely, allowing it to produce high-quality, real-world data on how well vaccines are working.”
“Israel’s HMOs … track demographics, comorbidities, and a trove of coronavirus metrics on infections, illnesses, and deaths. ‘We have rich individual-level data that allows us to provide real-world evidence in near–real time,’ [Clalit Health Services chief innovation officer, Ran] Balicer says.”
“Now, the effects of waning immunity may be beginning to show in Israelis vaccinated in early winter; a preprint published last month … found that protection from COVID-19 infection during June and July dropped in proportion to the length of time since an individual was vaccinated. People vaccinated in January had a 2.26 times greater risk for a breakthrough infection than those vaccinated in April.”
Unfortunately, we cannot rely on U.S. data to get a clear idea of how the COVID-19 shots are working, as the U.S. Centers for Disease Control and Prevention (CDC) has chosen not to track all breakthrough cases. As reported by ProPublica, the CDC stopped tracking and reporting all breakthrough cases as of May 1, opting to log only those that result in hospitalization or death.
As noted in the article, this irrational decision has “left the nation with a muddled understanding of COVID-19’s impact on the vaccinated.” It also prevents us from understanding how variants are spreading and whether those who have received the jab can still develop so-called long-haul syndrome. Individual states are also setting their own criteria for how they collect data on breakthrough cases, and this patchwork muddies the waters even further.
On Sept. 10, National File posted a shocking video on Twitter featuring senior doctors and a North Carolina marketing director discussing how they would count recovered COVID-19 patients as active COVID-19 hospitalization cases in an effort to inflate hospitalization rates. Why? A marketing ploy to scare people into getting the jab.
Additionally, a study showed nearly half of those hospitalized with COVID-19 have only mild symptoms or are asymptomatic. They were hospitalized for some other reason and just happened to test positive. These and other data manipulations make U.S. data on infection, hospitalization, and mortality rates almost useless.
The boosters in Israel were rolled out in response to obvious vaccine failure. Pfizer’s shot went from 95 percent effectiveness in December 2020 to 64 percent in early July and 39 percent by late July, when the Delta strain became predominant. While the country boasts one of the highest fully vaccinated rates in the world, they now also have one of the highest daily infection rates. That fact challenges the hallowed concept of vaccine-induced herd immunity for COVID-19.
On Aug. 1, the director of Israel’s Public Health Services, Dr. Sharon Alroy-Preis, announced half of all COVID-19 infections were among the fully vaccinated.
The vaccinated aren’t only susceptible to testing positive, though: They’re also increasingly likely to experience serious disease when infected. Double-jabbed Israelis started making up the bulk of serious COVID-19 infections in July, and by mid-August, 59 percent of serious cases were among those who had received two COVID injections.
Others have cited even higher numbers. On Aug. 5, Dr. Kobi Haviv, director of the Herzog Hospital in Jerusalem, appeared on Channel 13 News, reporting that 95 percent of severely ill COVID-19 patients were fully vaccinated, and that they made up 85 percent to 90 percent of COVID-related hospitalizations overall.
On Aug. 20, U.S. CDC Director Dr. Rochelle Walensky admitted that the Israeli data “suggest increased risk of severe disease amongst those vaccinated early.” Despite limited effectiveness, both the Israeli health ministry and CDC say the answer is booster shots.
Mass Vaccination Versus Natural Immunity
As we gain more insight into the virus and the vaccine, it begins to look as though natural immunity offers superior protection against reinfection. Why? Largely because it works on more levels to provide a far more comprehensive and robust immune response. When you recover from the infection, your body makes antibodies against all five proteins of the virus, plus memory T cells that remain even once antibody levels diminish.
This provides lifelong protection, unless you have impaired immune function. The immunity you receive from the COVID-19 jab is in the form of just one type of antibody—the antibody against the original SARS-CoV-2 spike protein. If that spike protein sufficiently mutates, those antibodies become useless.
As warned by Dr. Geert Vanden Bossche, those specific antibodies are also more robust than the nonspecific antibodies you get from natural infection, so they overtake any natural antibodies you may have. That means that those who have recovered from a COVID-19 infection and have gained natural antibodies lose this superior protection if they then get vaccinated.
Real-world data from Israel shows those who have received the COVID-19 jab are 6.72 times more likely to get infected than people with natural immunity.
Disturbingly, a study posted on Aug. 23 on the preprint server bioRxiv warns the Delta variant “is posed to acquire complete resistance to wild-type spike vaccines.”
The researchers found that, if four common mutations were to occur simultaneously in the receptor-binding domain of the Delta variant, the resulting virus wouldn’t only be immune to the neutralizing antibodies produced in response to Pfizer’s injection, but it would also enhance the infectivity of the virus.
This could essentially turn into a worst-case scenario that sets up those who have received the Pfizer shots for more severe illness when exposed to the virus than they would have experienced had they not gotten the shots.
Will Boosters Fail?
Initial reports from Israel suggest the third Pfizer dose has improved protection in the over-60 group, compared to those who only got two doses of Pfizer. According to Reuters:
“Breaking down statistics from Israel’s Gertner Institute and KI Institute, ministry officials said that among people aged 60 and over, the protection against infection provided from 10 days after a third dose was four times higher than after two doses. A third jab for over 60-year-olds offered five to six times greater protection after 10 days with regard to serious illness and hospitalization.”
Despite that, Dvir Aran, a biomedical data scientist at the Israel Institute of Technology, isn’t hopeful these boosters will solve the problem, telling Science the surge in COVID-19 cases is already so steep, “even if you get two-thirds of those 60-plus [boosted], it’s just going to give us another week, maybe two weeks until our hospitals are flooded” again.
In simple terms, the vaccines can’t keep up with the virus.
The Double Vaxxed Who Are Most at Risk
Data from the United Kingdom—where available COVID-19 shots include Pfizer, Moderna, AstraZeneca, and J&J/Janssen—is also starting to show vaccine failure, at least among older adults.
As of Aug. 15, 58 percent of COVID-19 patients admitted to hospital who were over the age of 50 had received two COVID jabs and 10 percent had received one dose. So, partially or fully “vaccinated” individuals made up 68 percent of hospitalizations.
Only in the 50 and younger category were a majority, 74 percent, of hospitalizations among the unvaccinated. The same applies to deaths. The unvaccinated only make up the majority of COVID-19 deaths in the under-50 age group. In the over-50 group, the clear majority, 70 percent, are either partially or fully “vaccinated.”
It’s also unclear whether hospitals in the UK are still designating anyone who is admitted and tests positive with a PCR test as a “COVID patient.” If so, people with broken bones or any number of other health problems who have no symptoms of COVID-19 at all might be unfairly lumped into the “unvaccinated COVID patient” total.
Why Do the Naturally Immune Need the COVID Shot?
If natural immunity is far superior and longer lasting than vaccine-induced immunity, why are those who have acquired it told to get vaccinated? The long-held medical fact that natural immunity is superior has been tossed aside as too inconvenient to matter in COVID-19. Instead, everyone, including those who have recovered from the infection, are being told they need to get the shots.
In a recent CNN interview, Dr. Anthony Fauci was asked why people with natural immunity are required to get the COVID-19 shot even though they’re likely more protected than “vaccinated” people. His reply was telling.
“That’s a really good point. I don’t have a really firm answer for you on that.”
Dr. Joseph Mercola is the founder of Mercola.com. An osteopathic physician, best-selling author, and recipient of multiple awards in the field of natural health, his primary vision is to change the modern health paradigm by providing people with a valuable resource to help them take control of their health. This article was originally published on Mercola.com